MedTrace Logo

Help Arthritis With Exercise in West Virginia

NCT00526201 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 323

Last updated 2015-12-24

No results posted yet for this study

Summary

The purpose of this project is to determine if an evidence-based, community-delivered physical activity program, EnhanceFitness, yields benefits for participants with arthritis. The 3-year project will: 1) conduct a meta-analysis of community-based exercise programs for adults, 2) implement and evaluate the EnhanceFitness program in West Virginia using a randomized, controlled (wait list) design, and 3) disseminate the results to community and public health partners. It is anticipated that participation in the EnhanceFitness program will result in reduced pain, improved physical function and physical activity levels for adults with arthritis.

Conditions

Interventions

BEHAVIORAL

12-weeks EnhanceFitness

EnhanceFitness class for 12 weeks, 3 times per week for 1 hour sessions.

BEHAVIORAL

Control

Participants randomized to the wait-list control group will continue their regular activities for 12 weeks and then be offered the exercise intervention (EnhanceFitness).

Sponsors & Collaborators

  • West Virginia University

    collaborator OTHER

  • Jennifer Hootman

    lead FED

Principal Investigators

  • Dina L Jones, PT, PHD · West Virginia University

  • Jennifer M Hootman, PhD · Centers for Disease Control and Prevention

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00526201 on ClinicalTrials.gov